Clincosm LogoSign in Get a demo

NEVPP: Professional Bladder Cancers and the Profession of Painter

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT05937555
Collaborator
(none)
150
Enrollment
6
Locations
10.5
Actual Duration (Months)
25
Patients Per Site
2.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This is a retrospective study on bladder cancer in French painters' population. The French agency ANSES collected data from all occupational and environmental diseases center in a specific database called RNV3P. We selected cases of bladder cancer in painters in four centers from 01/01/2010 to 31/12/2019. Those cases were analyzed in terms of occupational exposure, histology and sociodemographics data. Comparison between different histologic types of cancer, workplaces and occupational diseases process will be done.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    150 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Professional Bladder Cancers and the Profession of Painter: Retrospective Study of the RNV3P Database Files
    Actual Study Start Date :
    Mar 15, 2021
    Actual Primary Completion Date :
    Jan 28, 2022
    Actual Study Completion Date :
    Jan 28, 2022

    Outcome Measures

    Primary Outcome Measures

    1. histological type of bladder cancer [Inclusion ( Day 0)]

      international classification of bladder cancer TNM and histology

    Secondary Outcome Measures

    1. Occupational exposures [Inclusion (Day 0)]

      chemical exposures and workplaces during occupational painting activities

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • painters

    • age> 18 years

    • data from one of the French occupational diseases centers

    • approval letter

    Exclusion Criteria:

    • non-approval letter

    • age < 18 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHRU de Brest Brest France 29609
    2 CHU de Caen Caen France
    3 Ch Cherbourg Cherbourg France
    4 CH le Havre Le Havre France
    5 CHU de Lille Lille France
    6 CHU de Rouen Rouen France

    Sponsors and Collaborators

    • University Hospital, Brest

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Brest
    ClinicalTrials.gov Identifier:
    NCT05937555
    Other Study ID Numbers:
    • 29BRC19.0259 - NEVPP
    First Posted:
    Jul 10, 2023
    Last Update Posted:
    Jul 10, 2023
    Last Verified:
    Jul 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Keywords provided by University Hospital, Brest
    painter
    occupational cancer
    Additional relevant MeSH terms:
    Urinary Bladder Neoplasms

    Study Results

    No Results Posted as of Jul 10, 2023